Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00382785 · ClinicalTrials.gov registry record · NA

Psychosocial Outcomes in Online Cancer Support Groups

A NA study of Breast Cancer, sponsored by Christiana Care Health Services.

Completed
Registry status
NA
Development phase
51
Enrollment target
1
Study location

NCT00382785: Completed NA study of Breast Cancer, sponsored by Christiana Care Health Services.

NCT00382785 is a NA study of Breast Cancer that has completed, run by Christiana Care Health Services. The registered enrollment target is 51 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00382785, a NA study of Breast Cancer, has completed, sponsored by Christiana Care Health Services.

COMPLETED
Registry status
NA
Development phase
51 participants
Enrollment target
1
Study location

Study Summary

Purpose: The purpose of this project is to evaluate whether psychosocial outcomes in women with breast cancer differ based on the format of online group support. This objective will be addressed by the following specific aims: 1. Specific Aim #1 is to determine if there is a difference in depressive symptoms between women with breast cancer assigned to one of two treatment conditions: moderated online support or peer-led online support. • H1: Women with breast cancer who participate in moderated online support will report fewer depressive symptoms than women with breast cancer in peer led online support. 2. Specific Aim #2 is to determine if there is a difference in perceived social support between women with breast cancer who are assigned to one of two treatment conditions: moderated online support or peer-led online support. • H2: Women with breast cancer who participate in moderated online support will report greater perceived social support than women with breast cancer in peer-led online support. 3. Specific Aim #3 is to determine if there is a difference in quality of life in women with breast cancer who are assigned to one of two treatment conditions: moderated online support or peer-led online support. * H3: Women with breast cancer who participate in moderated online support will report better quality of life than women with breast cancer in peer-led online support. NOTE: Once the study began, it was obvious that we could not prevent anyone from joining a support group, if that was her choice. We also could not control if participants joined a second online support group or face-to-face group during the study. Therefore, we decided to omit a "usual care" (no support) group. The study was completed with just two groups: moderated and peer-support.

Primary Outcome

The Personal Resource Questionnaire 85 (PRQ85), Part II measures perceived social support and consists of 25 items in a seven-point Likert format which are rated from seven (7) strongly agree, to one (1) strongly disagree. Scores range from 25 to 175 with higher scores indicative of higher levels of perceived social support. Alpha reliability of the PRQ 85 has been demonstrated at \>.90

Conditions Studied

Interventions

  • BEHAVIORAL moderated support
  • BEHAVIORAL peer-led

Study Locations (1)

Delaware

  • University of Delaware - Newark

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2006-09
Est. Completion 2009-07
Phase NA
Christiana Care Health Services

82 total trials

What the finished NCT00382785 record still lists

NCT00382785 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 51 participants, a relatively small participant target, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (98% lower).

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which moderated support is the first listed.

NCT00382785 reports a single indexed study location in Delaware.

Frequently Asked Questions

What is clinical trial NCT00382785 about?

NCT00382785 is a clinical study titled "Psychosocial Outcomes in Online Cancer Support Groups". Purpose: The purpose of this project is to evaluate whether psychosocial outcomes in women with breast cancer differ based on the format of online group support. This objective will be addressed by the following specific aims: 1. Specific Aim #1 is to determine if there is a difference in depressiv...

What is the current status of trial NCT00382785?

This trial is currently completed. It is a NA study. The enrollment target is 51 participants. The study started on 2006-09. Estimated completion is 2009-07.

What conditions does trial NCT00382785 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT00382785?

The interventions under investigation include: moderated support (BEHAVIORAL), peer-led (BEHAVIORAL).

Who is sponsoring clinical trial NCT00382785?

This trial is sponsored by Christiana Care Health Services, which has 82 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00382785 being conducted?

This trial has 1 study location across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00382785's enrollment target sits among peer trials

51 782nd of 1224 higher than 437 of 1,224 other Breast Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02701153 · 51 participants · NA

    Phase II Study of 5-Day Hypofractionated Preoperative Radiation Therapy for Soft Tissue Sarcomas: Expansion Cohort

  • NCT03663790 · 51 participants · NA

    Effects of Gait Retraining on Lower Extremity Biomechanics

  • NCT03874052 · 51 participants · Phase 1

    Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

  • NCT04704661 · 51 participants · Phase 1

    Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00382785, the US trial registry maintained by the National Library of Medicine. NCT00382785 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.